insulin-like growth factor 1 raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-11-24. Anything still debated is marked as such rather than presented as settled.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Common analytical approaches include reversed-phase high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Peptide mapping after enzymatic digestion can verify the expected sequence. Immunoassays may be used to measure the compound or its downstream markers, but they can cross-react with related peptides and require careful validation. Impurity profiles typically include truncated sequences, oxidized methionine residues, and residual solvents from synthesis. Each method reports a different property, so no single assay establishes overall quality.
Storage claims vary across suppliers, and published stability data for specific formulations are limited. Extrapolating from related peptides is common but not a substitute for direct measurement. For research use, documentation such as a certificate of analysis is often requested to confirm identity and purity. What constitutes an acceptable purity threshold depends on the intended application. Open questions remain about how temperature excursions during shipping affect long-term peptide integrity. Independent verification by an end user is not routinely reported.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Because growth hormone is released in pulses, single measurements can misrepresent overall secretion. Investigators sometimes use repeated sampling or overnight profiles to capture the pattern rather than a single value. Provocative testing, in which a stimulus is given and the response is tracked over time, offers another way to characterize the axis. Each approach carries trade-offs between sensitivity, burden on the participant, and the influence of non-target variables.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
After the U.S. atomic bombs were dropped on Hiroshima and Nagasaki on August 6 and 9, 1945, an additional 130,000 people - in addition to the 100,000 immediate victims - died from the effects of radiation by the end of 1945. Some experienced the so-called walking ghost phase, an acute radiation sickness caused by a high equivalent dose of 6 to 20 Sievert after a lethal whole-body dose. The phase describes the period of apparent recovery of a patient between the onset of the first massive symptoms and the inevitable death. In the years that followed, a number of deaths from radiation-induced diseases were added. In Japan, the radiation-damaged survivors are called hibakusha (Japanese: 被爆者, lit. ''Explosion victim'') and are conservatively estimated to number about 100,000.
Compton had recently founded the American Research and Development Corporation (ARD) to spur the formation of new post-war industries. He introduced the founders to ARD's president, Georges Doriot. Doriot predicted the cancer treatment machines would be a commercial failure. Nevertheless, he perceived HVEC's leaders to be technically capable, and Compton persuaded him that ARD should have a startup with clear human benefits. Among more than 400 applications, Doriot selected the firm among ARD's first three investments. He offered the founders $200,000 in initial capitalization, leaving half the equity to them and their staff consultants. Compton arranged for HVEC to exclusively license MIT's Van de Graaff and Trump patents. Both Compton and Doriot served on the new company's board.
South Africa has an extensive logistics industry that supports the country's global trade competitiveness and economic integration. In 2024, the sector generated over half a trillion rand in annual economic output. The country has a robust logistics industry, the network of which supports its supply chain, from manufacturing to the point of consumption. As in other developed countries, SA's logistics sector consists of, among other things, physical infrastructure such as trucks, warehouses and other storage facilities, local and international courier companies, institutional knowledge, and a multimodal transport system including airports, sea ports, rail freight, and road freight systems. As of 2026, according to the World Bank, South Africa's logistics infrastructure and performance indices rank highly, continue to increase, and are comparable to those of China and the United States. In the 2023 World Bank Logistics Performance Index, South Africa ranked joint 19th place, out of 139 countries - an increase of 14 places since the previous year. In recent years, the country's logistics, and in particular its freight sector, has shifted away from state-owned operations and infrastructure, and more towards public investment and public private partnerships.
These brands are labeled as "grain-free" and list peas, lentils, or potatoes as the main ingredient. The top three brands associated with reports of cardiomyopathy are Acana with 67 reports, Zignature with 64, and Taste of the Wild with 53 reports. In 2022, the FDA released a follow-up report which superseded the 2019 research. The follow-up report stated the following:
Sources: en.wikipedia.org
RNA interference (RNAi) The sequence-specific suppression of gene expression, natural or artificial, by any of a variety of RNA species capable of repressing transcription or translation through a variety of mechanisms. In the traditional usage, RNAi refers to the process by which small interfering RNA (siRNA) or short hairpin RNA (shRNA) molecules, as part of an RNA-induced silencing complex (RISC), identify and cleave foreign double-stranded RNA molecules and then use the cleaved single-stranded fragments to hybridize with complementary sequences in target messenger RNA (mRNA) transcripts and thus promote their degradation or otherwise inhibit translation. The term is also sometimes used more broadly to include silencing by antisense RNA (asRNA).
Zverev then made only modest achievements in the succeeding weeks, losing to Learner Tien in the second round of the Mexican Open, to Tallon Griekspoor in the second round of Indian Wells, to Arthur Fils in the fourth round of the Miami Open, and to Matteo Berrettini in Monte-Carlo. In April, Zverev won his 3rd title in Munich and 24th overall on his birthday, winning in straight sets over Ben Shelton. Zverev was presented his trophy BMW by Dominic Thiem, and reclaimed the world No. 2 ranking from Alcaraz. The next week, he reached the round of 16 at the Madrid Open. During his third round match, Zverev was given a code violation for taking a photo of the ball mark of shot which Zverev considered to have been erroneously called in. Later, social media posts from the ATP Tour suggested that the Hawk-Eye call was correct and that Zverev likely took a picture of a different mark. Following this, Zverev failed to defend either his titles in Rome and Hamburg with a straight sets loss against an in-form Lorenzo Musetti and a three-set loss against Alexandre Müller, respectively. At the French Open where he was defending finalist points, Zverev advanced to the quarterfinals, where he was defeated by Novak Djokovic in a four-set match. On the grass, Zverev reached his third final of the year in Stuttgart, losing to Taylor Fritz in straight sets in his fifth consecutive loss against the American. He then reached the semifinals against Daniil Medvedev in Halle, losing in three sets.
=== Intermittent === Contrary to classic and intermediate MSUD, intermittent MSUD individuals will have normal growth and intellectual development. This type of MSUD is typically presented around 1 to 2 years of life. Other symptoms may include ataxia and semicoma. These symptoms may accelerate and worsen rapidly. Symptoms of lethargy and characterized odor of maple syrup will occur when the individual experiences stress, does not eat or develops an infection. The metabolic crisis leading to seizures, coma, and brain damage is still a possibility.
Inputs include clinical tests (cold ethyl chloride, EPT, hot-gutta percha, palpation), radiographic analysis (peri-apical and/or cone-beam computed tomography) and others. Thermal tests are subjective, and are therefore performed the compromised tooth and the adjacent and contralateral teeth, allowing the patient to compare them. Normal healthy teeth are used as a baseline for diagnoses. Key characteristics of symptomatic irreversible pulpitis include:
== Awards == 2000 – National Bleeding Disorders Foundation, Researcher of the Year award 2009 – Foundation Fighting Blindness, Board of Directors Award 2010 – American Society of Gene and Cell Therapy, Outstanding Achievement Award 2014 – Human Gene Therapy, Pioneer Award 2018 – Sanford Health's $1 million Lorraine Cross Award for innovation in medicine and science, shared with Jean Bennett 2022 – American Society of Gene and Cell Therapy, Jerry Mendell Award for Translational Science 2022 – Children's Hospital of Philadelphia, Gold Medal for transformative impact on children's health through gene therapy 2026 – Breakthrough Prize in Life Sciences
Sources: en.wikipedia.org
The team is launched into space on modified ballistic missiles and approaches the alien ship by stealth. Four of the avout destroy the ship's main weapon before dying in combat. The rest of the team boards the ship and temporarily pass out from breathing alien air. The narrative now parallelizes across multiple timelines. In one narrative, Fraa Jad awakens Erasmas and leads him through the ship toward the command center. Upon being discovered and attacked by alien soldiers, Fraa Jad detonates the neutron bombs. In another narrative, soldiers take Erasmas and Fraa Jad captive and bring them to parley with the leader of the peaceful faction. In the final narrative, Erasmas awakens in a hospital on the starship and learns that diplomatic negotiations are underway thanks to the successful destruction of the alien weapon. Erasmas is told that Fraa Jad died in an accident during the launch, contradicting the other narratives. It remains ambiguous which (or how many) of these contradictory narratives are real, or how the narratives have influenced each other. It is implied that some Millenarian avout are capable of operating simultaneously in multiple parallel timelines, and that the Millenarians had called the alien ship to Arbre to disrupt the subjugation of the Avout by the Sæcular Power. Erasmas attends a diplomatic summit where a funeral ceremony is held for those lost on both sides and a peace process begins between the aliens and the Arbrans. On Arbre itself, the Sæcular Power and the avout have agreed to cooperate as equal powers.
== Plot == Four years after the events of the first film, Professor Sherman Klump has created a de-aging formula. He is in a relationship with DNA researcher Denise Gaines, developer of a method to isolate genetic material. Despite his good fortune, Sherman's id alter ego, Buddy Love, has taken to sporadically controlling Sherman's body. Sherman becomes determined to permanently rid himself of Buddy when his antics ruin a dinner in honor of his father Cletus' retirement; and a marriage proposal to Denise. Despite his assistant, Jason, warning him of the harmful consequences, Sherman uses Denise's methodology to isolate and remove the DNA where Buddy has manifested. However, the Buddy genetic material grows into a sentient being when a hair from Jason's Basset Hound, Buster, accidentally lands in it. Sherman apologizes to Denise and they become engaged. Later, Dean Richmond informs them that Phleer Pharmaceuticals has offered Wellman College $150 million for the youth formula. Sherman and Denise then encounter the physically reformed Buddy at a movie theater, Buddy asks Sherman where his previous girlfriend Carla Purty is, but Sherman tells Buddy that he and Carla weren't in a romantic relationship, but rather close friends. Buddy pickpockets Sherman and learns of the $150 million offer. He subsequently visits the pharmaceutical company, making a rival bid of $149 million with Leanne Guilford, President of Acquisitions, for the youth formula. Sherman learns that the extraction has altered his body chemistry and that he is losing his intelligence.
=== Stability === Thionyl chloride has a long shelf life, however "aged" samples develop a yellow hue, possibly due to the formation of disulfur dichloride. It slowly decomposes to S2Cl2, SO2 and Cl2 at just above the boiling point. Thionyl chloride is susceptible to photolysis, which primarily proceeds via a radical mechanism. Samples showing signs of ageing can be purified by distillation under reduced pressure, to give a colourless liquid.
The production, distribution, and sale of cocaine products is restricted (and illegal in most contexts) in most countries as regulated by the Single Convention on Narcotic Drugs, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. In the United States the manufacture, importation, possession, and distribution of cocaine are additionally regulated by the 1970 Controlled Substances Act. Some countries, such as Bolivia, Colombia, and Peru, permit the cultivation of coca leaf for traditional consumption by the local indigenous population, but nevertheless, prohibit the production, sale, and consumption of cocaine. The provisions as to how much a coca farmer can yield annually is protected by laws such as the Bolivian Cato accord. In addition, some parts of Europe, the United States, and Australia allow processed cocaine for medicinal uses only.
== S == sarcoplasmic reticulum - satellite DNA - scientific notation - SDS-PAGE - second messenger - second messenger system - secondary structure - secretin - selectin - sensory receptor - sequence (biology) - sequence homology - sequence motif - sequencing - serine - serotonin - serotonin receptor - serpin - sexual reproduction - SH3 domain - SI - sigma factor - signal peptide - signal recognition particle - signal sequence - signal transduction - sincalide - skeleton - skin - smooth ER - sodium channel - sodium-hydrogen antiporter - soluble - solution - solvation - solvent - somatomedin - somatomedin receptor - somatostatin - somatostatin receptor - somatotropin - somatotropin receptor - somatotropin-releasing hormone - somatropin - sp1 transcription factor - spectrin - spectroscopy - src gene - src-family kinase - SSRI - starch - stem cell - stereochemistry - steroid 17alpha-monooxygenase - steroid 21-monooxygenase - steroid receptor - stimulatory gs G-protein - stoichiometry - structural biology - structural domain - Structural formula - structural motif - substance P - substrate - sugar - sulfur - supercoil - superfamily - superoxide - surface immunoglobulin - surface plasmon resonance - suspension (chemistry) - synapse - synthetic vaccine - systems biology
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
Refrigeration between 2 and 8 degrees Celsius with protection from light is the common recommendation. Many laboratories choose frozen storage at minus 20 degrees Celsius when the material will not be used soon. Repeated temperature cycling is generally avoided.